Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The Lancet. Global Health
|
October 14, 2017
Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship
Patricia McGettigan, Peter Roderick, Abhay Kadam, et al.
Lancet (London, England)
|
January 23, 2014
India should introduce a new Drugs Act
Peter Roderick, Rushikesh Mahajan, Patricia McGettigan, et al.
Diabetes Research and Clinical Practice
|
June 17, 2019
The global prevalence of tobacco use in type 2 diabetes mellitus patients: A systematic review and meta-analysis
Peter Roderick, Victoria Turner, Anne Readshaw, et al.
BMJ (Clinical Research Ed.)
|
April 2, 2020
Covid-19: why is the UK government ignoring WHO's advice?
Allyson M Pollock, Peter Roderick, K K Cheng, et al.
Plos Medicine
|
May 13, 2015
Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs
Patricia McGettigan, Peter Roderick, Rushikesh Mahajan, et al.
The Pediatric Infectious Disease Journal
|
March 19, 2011
Pyrazinamide plasma concentrations in young children with tuberculosis
Helen McIlleron, Marianne Willemse, Hendrik Simon Schaaf, et al.
Journal of Pharmaceutical Policy and Practice
|
November 11, 2023
Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics
Petra Brhlikova, Aashna Mehta, Patricia McGettigan, et al.
Bulletin of the World Health Organization
|
October 3, 2022
Systemic antibiotic sales and WHO recommendations, India
Aashna Mehta, Petra Brhlikova, Patricia McGettigan, et al.
Lancet (London, England)
|
January 31, 2012
How the Health and Social Care Bill 2011 would end entitlement to comprehensive health care in England
Allyson M Pollock, David Price, Peter Roderick, et al.
Journal of Pharmaceutical Policy and Practice
|
November 19, 2024
Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study
Paul Bogowicz, Aashna Mehta, Shruti Choudhary, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The Lancet. Global Health
|
October 14, 2017
Access, Watch, and Reserve antibiotics in India: challenges for WHO stewardship
Patricia McGettigan, Peter Roderick, Abhay Kadam, et al.
Lancet (London, England)
|
January 23, 2014
India should introduce a new Drugs Act
Peter Roderick, Rushikesh Mahajan, Patricia McGettigan, et al.
Diabetes Research and Clinical Practice
|
June 17, 2019
The global prevalence of tobacco use in type 2 diabetes mellitus patients: A systematic review and meta-analysis
Peter Roderick, Victoria Turner, Anne Readshaw, et al.
BMJ (Clinical Research Ed.)
|
April 2, 2020
Covid-19: why is the UK government ignoring WHO's advice?
Allyson M Pollock, Peter Roderick, K K Cheng, et al.
Plos Medicine
|
May 13, 2015
Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs
Patricia McGettigan, Peter Roderick, Rushikesh Mahajan, et al.
The Pediatric Infectious Disease Journal
|
March 19, 2011
Pyrazinamide plasma concentrations in young children with tuberculosis
Helen McIlleron, Marianne Willemse, Hendrik Simon Schaaf, et al.
Journal of Pharmaceutical Policy and Practice
|
November 11, 2023
Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics
Petra Brhlikova, Aashna Mehta, Patricia McGettigan, et al.
Bulletin of the World Health Organization
|
October 3, 2022
Systemic antibiotic sales and WHO recommendations, India
Aashna Mehta, Petra Brhlikova, Patricia McGettigan, et al.
Lancet (London, England)
|
January 31, 2012
How the Health and Social Care Bill 2011 would end entitlement to comprehensive health care in England
Allyson M Pollock, David Price, Peter Roderick, et al.
Journal of Pharmaceutical Policy and Practice
|
November 19, 2024
Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study
Paul Bogowicz, Aashna Mehta, Shruti Choudhary, et al.
Page
of 4